1Crisel RM.et al.Capsular polymer of Haemophilus influenzae type b.J.Biol Chem.250:4926-4930,1975.
2Schneerson R,et al.Immunity to diseases causes by Haemophilus influenzae type b II:specificity and some biologic characteristics of natural infection acquired and immunization induce antibodies to the capsular polysaccharide of Haemophilus influenzae type b.J.Immunol.107:1089,1971.
3Reinert P.et al.Tolerance et immunogenicite du vaccin polyosidique capsulaire anti-baemophilus influenzae type b.etude chez 325 enfants de 15 a 71 mois.Ann.Pediatr.(Paris).36:20-25,1989.
4Paul WE.et al.B-lymphocytes subpopulations and responste to polysaccharide antigens.In Sell SH.et al.Haemophilus influenzae:epidemiology and prevention of disease.Elsevier Science Publishing Co,New York,1982:121-128.
5Mosier DE.et al.Thymus-independent antigens:complexity of B-lymphocytes activation revealed.Immonol.Today 1982:3:217-222.
6Schneerson R,et al.Preparation,characterization,and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates,J Exp Mde.152:361-376,1980.
7Pabst HF.et al.Ontogeny of the immune response as a basis of a chidhood disease.J.Pdeiatr.1980:97:519-534.
8Insel RA.et al.Oligosaccharide-protein conjugate vassines induce and prime for oligoclonal IgG antibody response to the Haemophilus influenzae type b capsular polysaccharide in human infants.J.Exp.Med.1985:163:262-269.
9Claesson BA.et al.Clinical and immunological responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18 to 23 months old children.J.Pediatr.1988:112:695-702.
10Claesson BA.et al.Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae capsular polysaccharide tetanus toxoid conjugate.J.Pediatr.1989:114:97-100.
